Gregor Jemec

Gregor Jemec

Clinical Professor

Member of:

  • Dermatovenerology


  1. 2024
  2. Published

    An Explorative Study on Calcium Electroporation for Low-risk Basal Cell Carcinoma

    Wiegell, Stine Regin, Hendel, K., Fuchs, C. S. K., Gehl, Julie, Vissing, M., Bro, S. W., Troelsen, J. T., Jemec, Gregor & Hædersdal, Merete, 2024, In: Acta Dermato-Venereologica. 104, 7 p., adv19678.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Accepted/In press

    Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa: A cross-sectional study

    Omari, N., Simonsen, S., Gluud, Lise Lotte, Martin, H. M., Trelle, M. B., Jemec, Gregor, Skov, Lone & Näslund-Koch, C., 2024, (Accepted/In press) In: Journal of the European Academy of Dermatology and Venereology.

    Research output: Contribution to journalLetterResearchpeer-review

  4. Published

    Behandlung der Acne fulminans mit Tumornekrosefaktor-α-Inhibitoren – eine Übersicht klinischer Fälle und der Literatur

    Taudorf, E. H., Jensen, M. B., Bouazzi, D., Sand, C., Thomsen, Simon Francis, Jemec, Gregor & Saunte, Ditte Marie, 2024, In: JDDG - Journal of the German Society of Dermatology. 22, 1, p. 23-28 6 p.

    Research output: Contribution to journalReviewResearchpeer-review

  5. Published

    Diagnostic accuracy of a short-form version of the diagnostic criteria for primary hyperhidrosis

    Henning, M. A. S., Al-Rahimi, H. I., Jemec, Gregor & Pedersen, Ole Birger Vesterager, 2024, In: Acta Dermatovenerologica Alpina, Pannonica et Adriatica. 33, 1, p. 17-22 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Did We Forget about Social Determinants of Health in Dermatology?

    Christensen, E. M. M. & Jemec, Gregor, 2024, In: Acta Dermato-Venereologica. 104, 2 p., adv34034.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials

    Kimball, A. B., Jemec, Gregor, Sayed, C. J., Kirby, J. S., Prens, E., Ingram, J. R., Garg, A., Gottlieb, A. B., Szepietowski, J. C., Bechara, F. G., Giamarellos-Bourboulis, E. J., Fujita, H., Rolleri, R., Joshi, P., Dokhe, P., Muller, E., Peterson, L., Madden, C., Bari, M. & Zouboulis, C. C., 2024, In: The Lancet. 403, 10443, p. 2504-2519 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Global differences in tobacco use: who is using what?

    Medianfar, C. E. & Jemec, Gregor, 2024, In: British Journal of Dermatology. 190, 1, p. 117-118 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  9. Published

    Increased cancer incidence among patients with hidradenitis suppurativa - a Danish nationwide register study 1977-2017

    Andersen, R., Rostgaard, K., Pedersen, O., Jemec, Gregor & Hjalgrim, Henrik, 2024, In: Acta oncologica (Stockholm, Sweden). 63, p. 220-228 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Accepted/In press

    Increased risk of nonmelanoma skin cancer in patients with alpha-1 antitrypsin deficiency: A nationwide cohort study

    Korsbæk, N. J., Landt, E. M., Marott, S., Nordestgaard, Børge, Vinding, Gabrielle Randskov, Jemec, Gregor & Dahl, Morten, 2024, (Accepted/In press) In: Journal of the European Academy of Dermatology and Venereology.

    Research output: Contribution to journalLetterResearchpeer-review

  11. Published
Previous 1 2 3 4 5 6 7 8 ...47 Next

ID: 927829